These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 17579500)
21. Continuation treatment of major depressive disorder: is there a case for duloxetine? Norman TR; Olver JS Drug Des Devel Ther; 2010 Feb; 4():19-31. PubMed ID: 20368904 [TBL] [Abstract][Full Text] [Related]
23. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil. Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599 [TBL] [Abstract][Full Text] [Related]
24. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792 [TBL] [Abstract][Full Text] [Related]
25. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641 [TBL] [Abstract][Full Text] [Related]
26. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms. Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411 [TBL] [Abstract][Full Text] [Related]
27. Duloxetine: a review of its use in the management of major depressive disorder in older adults. Dhillon S Drugs Aging; 2013 Jan; 30(1):59-79. PubMed ID: 23239363 [TBL] [Abstract][Full Text] [Related]
28. Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder. Ye W; Zhao Y; Robinson RL; Swindle RW BMC Psychiatry; 2011 Jan; 11():19. PubMed ID: 21281479 [TBL] [Abstract][Full Text] [Related]
29. Duloxetine for the treatment of major depressive disorder. Nemeroff CB; Schatzberg AF; Goldstein DJ; Detke MJ; Mallinckrodt C; Lu Y; Tran PV Psychopharmacol Bull; 2002; 36(4):106-32. PubMed ID: 12858150 [TBL] [Abstract][Full Text] [Related]
30. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Bymaster FP; Lee TC; Knadler MP; Detke MJ; Iyengar S Curr Pharm Des; 2005; 11(12):1475-93. PubMed ID: 15892657 [TBL] [Abstract][Full Text] [Related]
31. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Westanmo AD; Gayken J; Haight R Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903 [TBL] [Abstract][Full Text] [Related]
32. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. Goldstein DJ; Lu Y; Detke MJ; Wiltse C; Mallinckrodt C; Demitrack MA J Clin Psychopharmacol; 2004 Aug; 24(4):389-99. PubMed ID: 15232330 [TBL] [Abstract][Full Text] [Related]
33. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. Delgado PL; Brannan SK; Mallinckrodt CH; Tran PV; McNamara RK; Wang F; Watkin JG; Detke MJ J Clin Psychiatry; 2005 Jun; 66(6):686-92. PubMed ID: 15960560 [TBL] [Abstract][Full Text] [Related]
34. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869 [TBL] [Abstract][Full Text] [Related]
35. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Gartlehner G; Thaler K; Hansen RA; Gaynes BN Drug Saf; 2009; 32(12):1159-73. PubMed ID: 19916583 [TBL] [Abstract][Full Text] [Related]
36. Duloxetine: a dual reuptake inhibitor. Dugan SE; Fuller MA Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980 [TBL] [Abstract][Full Text] [Related]
37. Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons. Eckert L; Lançon C BMC Psychiatry; 2006 Jul; 6():30. PubMed ID: 16867188 [TBL] [Abstract][Full Text] [Related]
38. Preclinical discovery of duloxetine for the treatment of depression. Torres-Sanchez S; Perez-Caballero L; Mico JA; Elorza J; Berrocoso E Expert Opin Drug Discov; 2012 Aug; 7(8):745-55. PubMed ID: 22680253 [TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder. Raskin J; Wiltse CG; Dinkel JJ; Walker DJ; Desaiah D; Katona C J Clin Psychopharmacol; 2008 Feb; 28(1):32-8. PubMed ID: 18204338 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. Thase ME; Pritchett YL; Ossanna MJ; Swindle RW; Xu J; Detke MJ J Clin Psychopharmacol; 2007 Dec; 27(6):672-6. PubMed ID: 18004135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]